骨ミネラル代謝異常治療の世界市場レポート 2024年

骨ミネラル代謝異常治療市場規模は近年力強く成長しています。2023年の30億6,000万米ドルから2024年には33億米ドルに、CAGR8.0％で拡大します。この実績期間の成長は、慢性腎臓病、高齢化、ミネラルと骨の障害に対する意識の高まり、骨ミネラル代謝異常治療の入手可能性の増加、可処分所得水準の上昇に起因しています。

骨ミネラル代謝異常治療市場規模は、今後数年間で力強い成長が見込まれます。2028年には年間平均成長率（CAGR）7.1％で43億4,000万米ドルに成長します。予測期間の成長は、QOL治療に対する需要の高まり、個別化医療に対する需要の高まり、ヘルスケアに対する政府支出、早期診断の重要性に対する意識の高まりに起因しています。予測期間の主な動向としては、医学研究の進展、医薬品開発、デジタルヘルス、生物学的治療、遠隔医療、遠隔モニタリングなどが挙げられます。

骨ミネラル代謝異常治療市場は、拡大する高齢者人口に牽引され、成長の態勢を整えています。この層は65歳以上の高齢者で構成され、筋力や骨量の減少に関連する問題に悩まされることが多く、その結果、体力が低下します。加齢に伴う骨、筋肉、関節の変化に対応するため、骨ミネラル代謝異常治療は骨を強化し、骨量の減少を遅らせるという重要な役割を果たします。世界保健機関（WHO）の予測によると、60歳以上の人口は2020年の10億人から2030年には14億人、さらに2050年には21億人に急増すると予想されています。さらに、80歳以上の人口は2020年の1億4,300万人から2050年には4億2,600万人へと3倍に増加します。その結果、高齢者人口の増加は骨ミネラル代謝異常治療市場拡大の重要な触媒として機能します。

慢性腎臓病の罹患率の上昇が骨ミネラル代謝異常治療市場の成長を牽引すると予測されます。慢性腎臓病（CKD）は、長期にわたる腎機能の漸減を特徴とします。CKDにおけるミネラルおよび骨障害の効果的な治療は、適切なミネラルバランスを維持し、骨の健康を保ち、これらの不均衡に関連する合併症を軽減することを目的としています。2022年3月現在、米国の医療情報源である国立医学図書館のデータによると、世界人口の10％を占める8億人以上の人々が、進行性の病気である慢性腎臓病を患っています。その結果、慢性腎臓病の有病率の増加が骨ミネラル代謝異常治療市場の成長を促進する主要因となっています。

2023年の骨ミネラル代謝異常治療市場で最大の地域は北米でした。骨ミネラル代謝異常治療レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東およびアフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の骨ミネラル代謝異常治療市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ダイエット
• 栄養
• 薬剤
• サプリメント
• 透析
• 世界の骨ミネラル代謝異常治療市場、流通チャネル別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界の骨ミネラル代謝異常治療市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 在宅ケア
• 専門クリニック
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の骨ミネラル代謝異常治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の骨ミネラル代謝異常治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 骨ミネラル代謝異常治療市場の競合情勢
• 骨ミネラル代謝異常治療市場の企業プロファイル
  • Pfizer Inc.
  • Merck &Co. Inc.
  • Bayer AG
  • Novartis AG
  • Bristol-Myers Squibb Company

第31章 その他の主要および革新的な企業

• Takeda Pharmaceutical Co. Ltd.
• Eli Lilly And Company
• Amgen Inc.
• GlaxoSmithKline plc
• Teva Pharmaceuticals Industries Ltd.
• Mylan N.V.
• Daiichi Sankyo Company Limited
• Servier Laboratories Pty Ltd.
• Sun Pharmaceutical Industries Ltd.
• Aurobindo Pharma Limited
• Cipla Limited
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals plc
• Glenmark Pharmaceuticals Ltd.
• Alkem Laboratories Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

“Mineral And Bone Disorder Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mineral and bone disorder treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mineral and bone disorder treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The mineral and bone disorder treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Treatment: Diet; Nutrition; Medication; Supplements; Dialysis
• 2) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 3) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Novartis AG; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Mineral and bone disorder treatment is a therapeutic approach recommended when there is an imbalance in the levels of calcium and phosphorus in the bloodstream. This treatment is aimed at regulating specific minerals and hormones in the blood to prevent damage to the bones and blood vessels.

The key treatments for mineral and bone disorders encompass dietary adjustments, nutritional interventions, medications, the use of supplements, and, in severe cases, dialysis. Dietary modifications involve consuming foods and beverages that promote bone health, reducing the risk of conditions like osteoporosis and mitigating further bone loss. These treatments can be made available through various distribution channels, including hospital pharmacies, online pharmacies, and retail pharmacies, and are tailored to different end users, such as hospitals, homecare settings, specialty clinics, and more.

The mineral and bone disorder treatment market research report is one of a series of new reports from The Business Research Company that provides mineral and bone disorder treatment market statistics, including mineral and bone disorder treatment industry global market size, regional shares, competitors with a mineral and bone disorder treatment market share, detailed mineral and bone disorder treatment market segments, market trends and opportunities and any further data you may need to thrive in the mineral and bone disorder treatment industry. This mineral and bone disorder treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mineral and bone disorder treatment market size has grown strongly in recent years. It will grow from $3.06 billion in 2023 to $3.3 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to chronic kidney disease, aging population, rising awareness of mineral and bone disorders, increased availability of mineral and bone disorder treatments, rising disposable income levels.

The mineral and bone disorder treatment market size is expected to see strong growth in the next few years. It will grow to $4.34 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to rising demand for quality of life treatments, growing demand for personalized medicine, government spending on healthcare, rising awareness of the importance of early diagnosis. Major trends in the forecast period include advancements in medical research, pharmaceutical developments, digital health, biologic therapies, telehealth and remote monitoring.

The mineral and bone disorder treatment market is poised for growth, driven by the expanding elderly population. This demographic segment comprises individuals aged 65 or older, and they often grapple with issues related to muscle and bone mass decline, resulting in weakened physical strength. To address age-related changes in bones, muscles, and joints, mineral and bone disorder treatments play a crucial role in strengthening bones and slowing down bone loss. As projected by the World Health Organization (WHO), the number of individuals aged 60 or older is anticipated to surge from 1 billion in 2020 to 1.4 billion by 2030 and further to 2.1 billion by 2050. Moreover, the population aged 80 and above is set to triple, growing from 143 million in 2020 to 426 million by 2050. Consequently, the growing elderly population acts as a significant catalyst for the mineral and bone disorder treatment market's expansion.

The rising incidence of chronic kidney diseases is anticipated to drive the growth of the mineral and bone disorder treatment market. Chronic kidney disease (CKD) is characterized by the gradual loss of kidney function over an extended period. Effective treatment of mineral and bone disorders in CKD aims to maintain appropriate mineral balance, preserve bone health, and mitigate the complications associated with these imbalances. As of March 2022, data from the National Library of Medicine, a US-based medical resource, indicates that over 800 million people globally, constituting 10% of the world's population, suffer from chronic kidney disease, a progressive ailment. Consequently, the increasing prevalence of chronic kidney diseases is a key factor propelling the growth of the mineral and bone disorder treatment market.

The limited access to healthcare in specific regions has the potential to impede the market's growth during the forecast period. Patients residing in these areas may encounter various obstacles, including a lack of convenient and affordable transportation, difficulties in taking time off from work, challenges in finding affordable childcare, limited healthcare facility operating hours, and extended waiting times. These barriers can prevent patients from receiving timely and appropriate care for bone and mineral disorders, resulting in adverse health outcomes and potentially reducing the demand for related treatments and products. For example, a survey conducted in December 2021 by the University of Southern California, a US-based public university, found that 30% of Americans reported that high out-of-pocket medical expenses prevented them from seeking treatment. In the United States, approximately 46 million individuals reside in rural areas, often lacking access to necessary healthcare services. As a result, limited healthcare accessibility in specific regions is posing a challenge to the growth of the mineral and bone disorder treatment market.

Prominent companies in the mineral and bone disorder treatment market are strategically focusing on the development and approval of new products to enhance their market position. The increasing prevalence of chronic kidney diseases, particularly among the aging population, has led to the approval of new drugs for mineral and bone disorders. An example of such an approved drug is TYMLOS (abaloparatide), which contains the active drug abaloparatide, a synthetic form of the human parathyroid hormone. For instance, in December 2022, Radius Health Inc., a biopharmaceutical company based in the United States, successfully obtained approval for TYMLOS (abaloparatide). This drug, an analog of parathyroid hormone-related peptide [PTHrP(1-34)], is designed for the treatment of increasing bone density in men with osteoporosis who are at a high risk of fractures. TYMLOS acts as an anabolic agent for bones by selectively activating the parathyroid hormone 1 receptor (PTH1R) expressed in osteoblasts and osteocytes, resulting in enhanced bone formation and density.

In May 2023, Abiogen Pharma Spa, an Italian pharmaceutical company, acquired EffRx Pharmaceuticals SA for $8.77 million. This strategic acquisition of a majority stake in EffRx aligns with Abiogen's growth strategy, serving as a springboard for international expansion and reinforcing its commitment to addressing osteoarticular and bone metabolism diseases. EffRx Pharmaceuticals SA, headquartered in Switzerland, is actively engaged in the treatment of various disorders, including mineral and bone disorders.

Major players in the mineral and bone disorder treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Takeda Pharmaceutical Co. Ltd., Eli Lilly And Company, Amgen Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Mylan N.V., Daiichi Sankyo Company Limited, Servier Laboratories Pty Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Zydus Cadila Healthcare Ltd., Alembic Pharmaceuticals Limited, Ajanta Pharma Ltd., Abiogen Pharma Spa, Melinta Therapeutics Inc., Intas Pharmaceuticals Ltd., Radius Health Inc., EffRx Pharmaceuticals SA .

North America was the largest region in the mineral and bone disorder treatment market in 2023. The regions covered in mineral and bone disorder treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mineral and bone disorder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mineral and bone disorder treatment market consists of revenues earned by entities by providing services such as treatment planning, patient education and support and multidisciplinary care. The market value includes the value of related goods sold by the service provider or included within the service offering. The mineral and bone disorder treatment market also includes sales of biphosphates, estrogens, phosphate binders, non-calcium, non-metal-based binders, magnesium-based binders, parathyroid hormone therapy, RANKL (receptor activator of nuclear factor kappa-B ligand) inhibitors and orthopedic implants which are used in providing mineral and bone disorder treatment-related services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Mineral And Bone Disorder Treatment Market Characteristics

3. Mineral And Bone Disorder Treatment Market Trends And Strategies

4. Mineral And Bone Disorder Treatment Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Mineral And Bone Disorder Treatment Market Size and Growth

• 5.1. Global Mineral And Bone Disorder Treatment Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Mineral And Bone Disorder Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Mineral And Bone Disorder Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Mineral And Bone Disorder Treatment Market Segmentation

• 6.1. Global Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Diet
• Nutrition
• Medication
• Supplements
• Dialysis
• 6.2. Global Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.3. Global Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users

7. Mineral And Bone Disorder Treatment Market Regional And Country Analysis

• 7.1. Global Mineral And Bone Disorder Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Mineral And Bone Disorder Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Mineral And Bone Disorder Treatment Market

• 8.1. Asia-Pacific Mineral And Bone Disorder Treatment Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Mineral And Bone Disorder Treatment Market

• 9.1. China Mineral And Bone Disorder Treatment Market Overview
• 9.2. China Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Mineral And Bone Disorder Treatment Market

• 10.1. India Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Mineral And Bone Disorder Treatment Market

• 11.1. Japan Mineral And Bone Disorder Treatment Market Overview
• 11.2. Japan Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Mineral And Bone Disorder Treatment Market

• 12.1. Australia Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Mineral And Bone Disorder Treatment Market

• 13.1. Indonesia Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Mineral And Bone Disorder Treatment Market

• 14.1. South Korea Mineral And Bone Disorder Treatment Market Overview
• 14.2. South Korea Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Mineral And Bone Disorder Treatment Market

• 15.1. Western Europe Mineral And Bone Disorder Treatment Market Overview
• 15.2. Western Europe Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Mineral And Bone Disorder Treatment Market

• 16.1. UK Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Mineral And Bone Disorder Treatment Market

• 17.1. Germany Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Mineral And Bone Disorder Treatment Market

• 18.1. France Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Mineral And Bone Disorder Treatment Market

• 19.1. Italy Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Mineral And Bone Disorder Treatment Market

• 20.1. Spain Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Mineral And Bone Disorder Treatment Market

• 21.1. Eastern Europe Mineral And Bone Disorder Treatment Market Overview
• 21.2. Eastern Europe Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Mineral And Bone Disorder Treatment Market

• 22.1. Russia Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Mineral And Bone Disorder Treatment Market

• 23.1. North America Mineral And Bone Disorder Treatment Market Overview
• 23.2. North America Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Mineral And Bone Disorder Treatment Market

• 24.1. USA Mineral And Bone Disorder Treatment Market Overview
• 24.2. USA Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Mineral And Bone Disorder Treatment Market

• 25.1. Canada Mineral And Bone Disorder Treatment Market Overview
• 25.2. Canada Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Mineral And Bone Disorder Treatment Market

• 26.1. South America Mineral And Bone Disorder Treatment Market Overview
• 26.2. South America Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Mineral And Bone Disorder Treatment Market

• 27.1. Brazil Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Mineral And Bone Disorder Treatment Market

• 28.1. Middle East Mineral And Bone Disorder Treatment Market Overview
• 28.2. Middle East Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Mineral And Bone Disorder Treatment Market

• 29.1. Africa Mineral And Bone Disorder Treatment Market Overview
• 29.2. Africa Mineral And Bone Disorder Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Mineral And Bone Disorder Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Mineral And Bone Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Mineral And Bone Disorder Treatment Market Competitive Landscape And Company Profiles

• 30.1. Mineral And Bone Disorder Treatment Market Competitive Landscape
• 30.2. Mineral And Bone Disorder Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merck & Co. Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Bayer AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Novartis AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Bristol-Myers Squibb Company
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Mineral And Bone Disorder Treatment Market Other Major And Innovative Companies

• 31.1. Takeda Pharmaceutical Co. Ltd.
• 31.2. Eli Lilly And Company
• 31.3. Amgen Inc.
• 31.4. GlaxoSmithKline plc
• 31.5. Teva Pharmaceuticals Industries Ltd.
• 31.6. Mylan N.V.
• 31.7. Daiichi Sankyo Company Limited
• 31.8. Servier Laboratories Pty Ltd.
• 31.9. Sun Pharmaceutical Industries Ltd.
• 31.10. Aurobindo Pharma Limited
• 31.11. Cipla Limited
• 31.12. Dr. Reddy's Laboratories Ltd.
• 31.13. Hikma Pharmaceuticals plc
• 31.14. Glenmark Pharmaceuticals Ltd.
• 31.15. Alkem Laboratories Ltd.

32. Global Mineral And Bone Disorder Treatment Market Competitive Benchmarking

33. Global Mineral And Bone Disorder Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Mineral And Bone Disorder Treatment Market

35. Mineral And Bone Disorder Treatment Market Future Outlook and Potential Analysis

• 35.1 Mineral And Bone Disorder Treatment Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Mineral And Bone Disorder Treatment Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Mineral And Bone Disorder Treatment Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer